Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Biogen Stock Slumped Last Year

TheMotleyFool

0 0

Biotech heavyweight Biogen (NASDAQ: BIIB) failed to follow the broader industry higher last year. Despite biotech stocks at large posting market-beating gains in 2019, Biogen's shares actually lost 1.4% of their value last year, according to data from S&P Global Market Intelligence.

Biogen's stock lost ground for three key reasons in 2019:

Image source: Getty Images.

Source Fool.com

Like: 0

BIIB

Share